Stanley-Laman Group’s Zimmer Biomet ZBH Stock Holding History

Stanley-Laman Group’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,495	Closed	-$218K	–	246
2023 Q2	$218K	Buy	+1,495	New	+$203K	0.04%	222
2017 Q1	–	Sell	-2,066	Closed	-$207K	–	291
2016 Q4	$207K	Sell	2,066 -223	-10%	-$23.9K	0.06%	253
2016 Q3	$289K	Hold	2,289	–	–	0.12%	166
2016 Q2	$267K	Buy	2,289 +23	+1%	+$2.6K	0.1%	189
2016 Q1	$235K	Buy	2,266 +206	+10%	+$19.9K	0.04%	235
2015 Q4	$205K	Hold	2,060	–	–	0.04%	309
2015 Q3	$188K	Hold	2,060	–	–	0.04%	304
2015 Q2	$218K	Hold	2,060	–	–	0.04%	279
2015 Q1	$235K	Hold	2,060	–	–	0.04%	277
2014 Q4	$227K	Hold	2,060	–	–	0.04%	284
2014 Q3	$201K	Hold	2,060	–	–	0.04%	275
2014 Q2	$208K	Buy	+2,060	New	+$201K	0.04%	271

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Stanley-Laman Group's ZBH Position: Q3 2023 in Review

Stanley-Laman Group sold out of Zimmer Biomet (ZBH) in Q3 2023, closing a stake of 1,495 shares — an estimated $218K sold.

Stanley-Laman Group first reported a position in ZBH in Q2 2014 and held it in 12 quarters. The position peaked at $289K in Q3 2016. 1,016 funds tracked by Wall St. Rank hold ZBH as of Q3 2023.

Stanley-Laman Group reported no remaining Zimmer Biomet position as of Q3 2023 after selling out during the quarter.
Stanley-Laman Group sold 1,495 Zimmer Biomet shares in Q3 2023, an estimated $218K.
Stanley-Laman Group first reported a position in Zimmer Biomet in Q2 2014 and held it in 12 quarters.
Stanley-Laman Group's Zimmer Biomet position peaked at $289K in Q3 2016.
1,016 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2023.

Based on Stanley-Laman Group's 13F filing for Q3 2023, filed 16 Oct 2023.